Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the Histamine-3 Receptor Inverse Agonist Pitolisant on Alcohol Self-Administration in Heavy Drinkers

NCT04596267 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT04596267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04596267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the Histamine-3 Receptor Inverse Agonist Pitolisant on Alcohol Self-Administration in Heavy Drinkers
Lead sponsor
Boston Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
September 13, 2021
Completion date
February 3, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, alcohol use disorder